STAGE II RECTAL CANCER AJCC V8
Clinical trials for STAGE II RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug chemo may help rectal cancer patients skip surgery
Disease control OngoingThis study compares a three-drug chemotherapy combination (FOLFIRINOX) against standard two-drug combinations (FOLFOX or CAPOX) after radiation in people with stage II or III rectal cancer. The goal is to see if the stronger regimen leads to a complete disappearance of the tumor,…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
New hope: personalized therapy for HIV patients with anal cancer
Disease control OngoingThis study tests a personalized approach for people with HIV and anal cancer. For low-risk patients, standard chemotherapy and radiation are used. For high-risk patients, the immunotherapy drug nivolumab is added after standard treatment to help prevent the cancer from coming bac…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
Immunotherapy-Radiation combo shows promise against rectal cancer
Disease control OngoingThis study tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) along with a short course of radiation can shrink advanced rectal tumors before surgery. About 31 adults with stage II or III rectal cancer that has a specific genetic feature (MSI-H/dMMR) will rec…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Cancer costs under the microscope: new study follows Patients' financial struggles
Knowledge-focused OngoingThis study looks at how cancer treatment affects the finances of people with stage I to III colon or rectal cancer. Researchers will ask about 565 patients' costs and quality of life over a year. The goal is to understand the financial burden and help doctors better support patie…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 26, 2026 11:39 UTC